@conference{af2734799df0438996bb9951693a2fbe,
title = "Outcomes of KRAS mutated, EGFR mutated, ALK mutated and wildtype patients in non-small cell lung cancer brain metastases.",
author = "Yasmeen Rauf and Vineeth Tatineni and Oshea, \{Patrick joseph\} and Xuefei Jia and Peereboom, \{David M.\} and Ahluwalia, \{Manmeet Singh\}",
note = "e21028 Background: Non-small cell lung cancer (NSCLC) is the most common primary tumor leading to brain metastases. Multiple genetic markers have been profiled in NSCLC patients for potential targeted therapies. EGFR is mutated in up 50\% of NSCLCs, while ALK is mutated in around 4-7\%.; Journal of Clinical Oncology ; Conference date: 02-06-2023",
year = "2021",
month = may,
day = "20",
doi = "10.1200/JCO.2021.39.15\_SUPPL.E21028",
language = "American English",
}